Requip (Ropinirole): Dopaminergic Therapy for Parkinson’s and Restless Legs Syndrome - Evidence-Based Review

Product Description Requip, known generically as ropinirole, is a non-ergoline dopamine agonist. It functions by directly stimulating dopamine receptors in the brain, specifically targeting the D2 sub-family. This pharmacological action is central to its therapeutic use in managing conditions characterized by dopamine deficiency or dysregulation. It is not a dietary supplement or a medical device in the conventional sense, but a prescription medication with a well-defined and potent mechanism. It is available in immediate-release and extended-release (Requip XL) oral formulations, allowing for tailored treatment regimens based on individual patient needs and disease stages.